FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 151 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $312,000 | +305.2% | 8,303 | -49.4% | 0.00% | +50.0% |
Q3 2020 | $77,000 | -28.0% | 16,425 | -6.7% | 0.00% | -33.3% |
Q2 2020 | $107,000 | -37.8% | 17,610 | -53.3% | 0.00% | -57.1% |
Q4 2019 | $172,000 | +224.5% | 37,690 | +174.6% | 0.01% | +133.3% |
Q3 2019 | $53,000 | -36.9% | 13,726 | -1.6% | 0.00% | -40.0% |
Q2 2019 | $84,000 | – | 13,955 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 115,500 | $2,531,000 | 0.89% |
AWM Investment Company, Inc. | 150,000 | $3,288,000 | 0.64% |
BB BIOTECH AG | 827,500 | $18,139,000 | 0.51% |
Virtus ETF Advisers LLC | 17,371 | $381,000 | 0.48% |
Rock Springs Capital Management LP | 425,000 | $9,316,000 | 0.42% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,728 | $9,880,000 | 0.39% |
Telemetry Investments, L.L.C. | 44,176 | $968,000 | 0.37% |
RTW INVESTMENTS, LP | 100,377 | $2,200,000 | 0.37% |
Eventide Asset Management | 315,000 | $6,905,000 | 0.36% |
ACUTA CAPITAL PARTNERS, LLC | 52,500 | $1,151,000 | 0.22% |